Announcement of Solicitation of Written Comments on Healthy People 2030 Objectives, 71580-71581 [2023-22805]
Download as PDF
<![CDATA[
71580
Federal Register / Vol. 88, No. 199 / Tuesday, October 17, 2023 / Notices
Dated: October 11, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
Intended Recipient of the Award: The
University of Kentucky.
Amount of Non-Competitive Award:
One award for $250,000.
Project Period: September 1, 2023, to
August 31, 2024.
CFDA Number: 93.155.
Award Instrument: Supplement.
Authority: Social Security Act section
711(b) (42 U.S.C. 912(b)).
Announcing funding
supplement for Rural Health and
Economic Development Analysis
Program.
ACTION:
[FR Doc. 2023–22842 Filed 10–16–23; 8:45 am]
BILLING CODE 4164–01–P
HRSA provided additional
award funds to the Rural Health and
Economic Development Analysis
Program recipient to produce a research
project that quantifies the relationships
between health care and economic
factors in rural communities.
SUMMARY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
FOR FURTHER INFORMATION CONTACT:
Rural Health and Economic
Development Analysis Program
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
AGENCY:
Karis Tyner, Federal Office of Rural
Health Policy, HRSA, at ktyner@
hrsa.gov and (240) 645–5756.
SUPPLEMENTARY INFORMATION:
TABLE 1—RECIPIENT AND AWARD AMOUNT
Grant No.
Award recipient name
City, state
5 U1ZRH33331 .......................
The University of Kentucky ......................................................
Lexington, KY .........................
Justification: This funding will
provide a one-time supplement to the
University of Kentucky via the Rural
Health and Economic Development
Analysis Program with a budget period
of September 2023 through August
2024. This supplement will allow the
University of Kentucky to build on past
and ongoing projects supported by
HRSA to improve health care in rural
areas by advancing the knowledge base
regarding the economic impacts of local
health care sectors on rural economies.
Carole Johnson,
Administrator.
[FR Doc. 2023–22814 Filed 10–16–23; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Announcement of Solicitation of
Written Comments on Healthy People
2030 Objectives
Office of Disease Prevention
and Health Promotion, Office of the
Assistant Secretary of Health, Office of
the Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
The U.S. Department of
Health and Human Services (HHS)
solicits written comments from the
public on the current Healthy People
2030 objectives, and written comments
from the public proposing additional
new core, developmental, or research
objectives or topics to be included in
Healthy People 2030. Public comment
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:02 Oct 16, 2023
Jkt 262001
informed the development of Healthy
People 2030. HHS will provide
opportunities for public input
periodically throughout the decade to
ensure Healthy People 2030 reflects
current public health priorities and
public input. The updated set of
Healthy People 2030 objectives and
topics will be incorporated on https://
health.gov/healthypeople. This updated
set will reflect further review and
deliberation by Federal Healthy People
topic area workgroups, the Federal
Interagency Workgroup on Healthy
People 2030, and other Federal subject
matter experts.
DATES: Written comments will be
accepted through 11:59 p.m. ET,
November 20, 2023.
ADDRESSES: Written comments should
be submitted by email to
HP2030Comment@hhs.gov.
FOR FURTHER INFORMATION CONTACT: Erik
Orta, Office of Disease Prevention and
Health Promotion, U.S. Department of
Health and Human Services, 1101
Wootton Parkway, Suite 420, Rockville,
MD 20852; Phone: 240–268–0823;
Email: HP2030@hhs.gov.
SUPPLEMENTARY INFORMATION: Since
1980, Healthy People has provided a
comprehensive set of national health
promotion and disease prevention
objectives with 10-year targets aimed at
improving the health of all. Healthy
People 2030 objectives present a picture
of the nation’s health at the beginning
of the decade, establish national goals
and targets to be achieved by the year
2030, and monitor progress over time.
The U.S. Department of Health and
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
Supplemental
award amount
$250,000
Human Services (HHS) is soliciting the
submission of written comments
regarding the current Healthy People
2030 objectives. The public is also
invited to submit proposals for
additional new core, developmental, or
research objectives that meet the criteria
outlined below.
Healthy People 2030 is the product of
an extensive collaborative process that
relies on input from a diverse array of
individuals and organizations, both
within and outside the Federal
Government, with a common interest in
improving the nation’s health. Public
comments were a cornerstone of
Healthy People 2030’s development.
During the first phase of planning for
Healthy People 2030, HHS asked for the
public’s comments on the initiative’s
vision, mission, and overarching goals.
Those comments helped set the
framework for Healthy People 2030. The
public was also invited to submit
comments on proposed Healthy People
2030 objectives, which helped shape the
current set of Healthy People 2030
objectives. HHS most recently solicited
comments on one new objective during
the 2022 public comment period from
October 24, 2022, through December 2,
2022, and three new proposed
objectives during the 2021 public
comment period from December 3,
2021, through January 10, 2022. These
new objectives, which were developed
by Healthy People 2030 subject matter
experts, meet specific criteria, and
reflect public input, are now accessible
on https://health.gov/healthypeople.
While there are no new objectives
being proposed at this time, the public
E:\FR\FM\17OCN1.SGM
17OCN1
Federal Register / Vol. 88, No. 199 / Tuesday, October 17, 2023 / Notices
is invited to provide comment on the
current Healthy People 2030 objectives
and propose additional core,
developmental, or research objectives
for consideration that address critical
public health issues. Proposed new
objectives must meet all the objective
selection criteria (see below). The public
is also invited to propose new topics to
be considered for inclusion in Healthy
People 2030.
Objective Selection Criteria
Core Objectives
Core objectives must meet the
following five criteria to be included in
Healthy People 2030. Core objectives
should (1) have a reliable, nationally
representative data source with baseline
data no older than 2015; (2) have at least
two additional data points beyond the
baseline during the decade; (3) be of
national importance; (4) have effective,
evidence-based interventions available
to achieve the objective; and (5) have
data to help address disparities and
achieve health equity.
Developmental Objectives
Developmental objectives will have
the following characteristics: (1)
represent high priority issues; (2) do not
have reliable baseline data yet; and (3)
have evidence-based interventions
available.
Research Objectives
lotter on DSK11XQN23PROD with NOTICES1
Research objectives will have the
following characteristics: (1) represent
key opportunities to make progress in
areas with limited prior research, a high
health or economic burden, or
significant disparities between
population groups; (2) may or may not
have reliable baseline data; and (3) do
not have evidence-based interventions
available.
Written comments and evidencebased information should be submitted
by email to HP2030Comment@hhs.gov
by 11:59 p.m. ET on November 20, 2023.
Comments received in response to this
notice will be reviewed and considered
by the Healthy People topic area
workgroups, Federal Interagency
Workgroup on Healthy People 2030, and
other Federal subject matter experts.
Paul Reed,
Deputy Assistant Secretary for Health, Office
of Disease Prevention and Health Promotion.
[FR Doc. 2023–22805 Filed 10–16–23; 8:45 am]
BILLING CODE 4150–32–P
VerDate Sep<11>2014
17:02 Oct 16, 2023
Jkt 262001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Speech, Language, and Motor
Function.
Date: November 8, 2023.
Time: 10:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sara Louise Hargrave,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170,
Bethesda, MD 20892, (301) 443–7193,
hargravesl@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: The Cancer Biotherapeutics
Development (CBD).
Date: November 13–14, 2023.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Laurie Ann Shuman Moss,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 867–5309, laurie.shumanmoss@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Musculoskeletal, Orthopedic, Oral,
Dermatology and Rheumatology.
Date: November 15–16, 2023.
Time: 8:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aftab A. Ansari, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
71581
Health, 6701 Rockledge Drive, Room 4108,
MSC 7814, Bethesda, MD 20892, (301) 237–
9931, ansaria@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–22–
180: Maximizing Investigators’ Research
Award (MIRA) (R35-Clinical Trial Optional).
Date: November 15–16, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Heidi B. Friedman, Ph.D.,
Senior Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 907–H,
Bethesda, MD 20892, (301) 379–5632,
hfriedman@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Arthritis, Connective Tissue and
Skin.
Date: November 15, 2023.
Time: 11:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Richard Michael Lovering,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000J,
Bethesda, MD 20892, (301) 867–5309,
loveringrm@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cell and Developmental Biology of
Eye.
Date: November 15, 2023.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Rass M. Shayiq, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2182,
MSC 7818, Bethesda, MD 20892, (301) 435–
2359, shayiqr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: The Cancer Drug Development and
Therapeutics (CDDT).
Date: November 16–17, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lilia Topol, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6192,
MSC 7804, Bethesda, MD 20892, 301–451–
0131, ltopol@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Instrumentation, Environmental,
and Occupational Safety.
E:\FR\FM\17OCN1.SGM
17OCN1
]]>Agencies
[Federal Register Volume 88, Number 199 (Tuesday, October 17, 2023)]
[Notices]
[Pages 71580-71581]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-22805]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Announcement of Solicitation of Written Comments on Healthy
People 2030 Objectives
AGENCY: Office of Disease Prevention and Health Promotion, Office of
the Assistant Secretary of Health, Office of the Secretary, Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The U.S. Department of Health and Human Services (HHS)
solicits written comments from the public on the current Healthy People
2030 objectives, and written comments from the public proposing
additional new core, developmental, or research objectives or topics to
be included in Healthy People 2030. Public comment informed the
development of Healthy People 2030. HHS will provide opportunities for
public input periodically throughout the decade to ensure Healthy
People 2030 reflects current public health priorities and public input.
The updated set of Healthy People 2030 objectives and topics will be
incorporated on https://health.gov/healthypeople. This updated set will
reflect further review and deliberation by Federal Healthy People topic
area workgroups, the Federal Interagency Workgroup on Healthy People
2030, and other Federal subject matter experts.
DATES: Written comments will be accepted through 11:59 p.m. ET,
November 20, 2023.
ADDRESSES: Written comments should be submitted by email to
[email protected].
FOR FURTHER INFORMATION CONTACT: Erik Orta, Office of Disease
Prevention and Health Promotion, U.S. Department of Health and Human
Services, 1101 Wootton Parkway, Suite 420, Rockville, MD 20852; Phone:
240-268-0823; Email: [email protected].
SUPPLEMENTARY INFORMATION: Since 1980, Healthy People has provided a
comprehensive set of national health promotion and disease prevention
objectives with 10-year targets aimed at improving the health of all.
Healthy People 2030 objectives present a picture of the nation's health
at the beginning of the decade, establish national goals and targets to
be achieved by the year 2030, and monitor progress over time. The U.S.
Department of Health and Human Services (HHS) is soliciting the
submission of written comments regarding the current Healthy People
2030 objectives. The public is also invited to submit proposals for
additional new core, developmental, or research objectives that meet
the criteria outlined below.
Healthy People 2030 is the product of an extensive collaborative
process that relies on input from a diverse array of individuals and
organizations, both within and outside the Federal Government, with a
common interest in improving the nation's health. Public comments were
a cornerstone of Healthy People 2030's development. During the first
phase of planning for Healthy People 2030, HHS asked for the public's
comments on the initiative's vision, mission, and overarching goals.
Those comments helped set the framework for Healthy People 2030. The
public was also invited to submit comments on proposed Healthy People
2030 objectives, which helped shape the current set of Healthy People
2030 objectives. HHS most recently solicited comments on one new
objective during the 2022 public comment period from October 24, 2022,
through December 2, 2022, and three new proposed objectives during the
2021 public comment period from December 3, 2021, through January 10,
2022. These new objectives, which were developed by Healthy People 2030
subject matter experts, meet specific criteria, and reflect public
input, are now accessible on https://health.gov/healthypeople.
While there are no new objectives being proposed at this time, the
public
[[Page 71581]]
is invited to provide comment on the current Healthy People 2030
objectives and propose additional core, developmental, or research
objectives for consideration that address critical public health
issues. Proposed new objectives must meet all the objective selection
criteria (see below). The public is also invited to propose new topics
to be considered for inclusion in Healthy People 2030.
Objective Selection Criteria
Core Objectives
Core objectives must meet the following five criteria to be
included in Healthy People 2030. Core objectives should (1) have a
reliable, nationally representative data source with baseline data no
older than 2015; (2) have at least two additional data points beyond
the baseline during the decade; (3) be of national importance; (4) have
effective, evidence-based interventions available to achieve the
objective; and (5) have data to help address disparities and achieve
health equity.
Developmental Objectives
Developmental objectives will have the following characteristics:
(1) represent high priority issues; (2) do not have reliable baseline
data yet; and (3) have evidence-based interventions available.
Research Objectives
Research objectives will have the following characteristics: (1)
represent key opportunities to make progress in areas with limited
prior research, a high health or economic burden, or significant
disparities between population groups; (2) may or may not have reliable
baseline data; and (3) do not have evidence-based interventions
available.
Written comments and evidence-based information should be submitted
by email to [email protected] by 11:59 p.m. ET on November 20,
2023. Comments received in response to this notice will be reviewed and
considered by the Healthy People topic area workgroups, Federal
Interagency Workgroup on Healthy People 2030, and other Federal subject
matter experts.
Paul Reed,
Deputy Assistant Secretary for Health, Office of Disease Prevention and
Health Promotion.
[FR Doc. 2023-22805 Filed 10-16-23; 8:45 am]
BILLING CODE 4150-32-P
